| 6.05 Data as of May 24 |  +0.05 / +0.83%Today’s Change | 4.95 Today|||52-Week Range 8.65 | -18.46% Year-to-Date |
| Previous close | 6.00 |
| Today’s open | 5.79 |
| Day’s range | 5.75 - 6.10 |
| Volume | 3,900 |
| Average volume (3 months) | 1,055 |
| Market cap | $69.4M |
| Dividend yield | -- |
| Earnings growth (last year) | +45.45% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 17.92 |
| No competitors data available. |
| Last reporting date | September 8, 2008 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$1.2M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Executive Director David Grossman |
Chief Financial Officer & Deputy CEO Ronen Twito, CPA |
Corporate headquarters Herzliya, -- |
.
